Stock Events

Stock Events

Denali Therapeutics (DNLI) Q3 2023 Earnings

7NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.82

-0.11

0.59

1.3

Details

Expected EPS

-0.82

Actual EPS

-0.72

Surprise EPS

0.1

Surprise Percent

+12.2%

Description

Denali Therapeutics (DNLI) has reported earnings of -0.72 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.